Simulations Plus (NASDAQ:SLP) Announces Earnings Results

Simulations Plus (NASDAQ:SLP) announced its quarterly earnings data on Tuesday. The technology company reported $0.19 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.04, Briefing.com reports. The firm had revenue of $18.54 million for the quarter, compared to analyst estimates of $17.92 million. Simulations Plus had a return on equity of 7.80% and a net margin of 14.36%. The business’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same period last year, the company earned $0.20 EPS. Simulations Plus updated its FY24 guidance to $0.54-0.56 EPS and its FY 2024 guidance to 0.540-0.560 EPS.

Simulations Plus Price Performance

SLP traded down $6.97 during trading on Thursday, hitting $39.89. 340,703 shares of the stock traded hands, compared to its average volume of 109,728. Simulations Plus has a twelve month low of $32.69 and a twelve month high of $52.69. The company has a market cap of $797.40 million, a price-to-earnings ratio of 75.26 and a beta of 0.72. The business has a 50 day moving average price of $47.68 and a 200 day moving average price of $44.15.

Simulations Plus Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 5th. Shareholders of record on Monday, July 29th will be given a dividend of $0.06 per share. The ex-dividend date is Monday, July 29th. This represents a $0.24 annualized dividend and a yield of 0.60%. Simulations Plus’s dividend payout ratio is currently 45.28%.

Insider Buying and Selling at Simulations Plus

In other Simulations Plus news, Director Daniel L. Weiner sold 3,250 shares of the business’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $48.31, for a total transaction of $157,007.50. Following the sale, the director now owns 8,759 shares of the company’s stock, valued at $423,147.29. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, Director Daniel L. Weiner sold 3,250 shares of the business’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $48.31, for a total value of $157,007.50. Following the sale, the director now owns 8,759 shares of the company’s stock, valued at $423,147.29. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction on Wednesday, May 1st. The stock was sold at an average price of $45.95, for a total transaction of $919,000.00. Following the completion of the sale, the director now directly owns 3,580,857 shares in the company, valued at approximately $164,540,379.15. The disclosure for this sale can be found here. Insiders sold a total of 44,500 shares of company stock worth $2,072,198 over the last three months. Corporate insiders own 20.90% of the company’s stock.

Analysts Set New Price Targets

SLP has been the topic of a number of analyst reports. Craig Hallum reissued a “buy” rating and issued a $56.00 price target on shares of Simulations Plus in a research note on Wednesday. William Blair initiated coverage on Simulations Plus in a research note on Friday, June 28th. They issued an “outperform” rating on the stock. Finally, Oppenheimer increased their price target on Simulations Plus from $55.00 to $65.00 and gave the company an “outperform” rating in a research note on Thursday, June 13th.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.